Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation Valeria BuccheriWolney Gois BarretoVanderson Rocha Review Article 12 October 2018 Pages: 2269 - 2278
The optimal timing of radiotherapy in the combined modality therapy for limited-stage extranodal NK/T cell lymphoma (ENKTL): a systematic review and meta-analysis Shaoxuan HuDaobin ZhouWei Zhang Review Article 20 August 2018 Pages: 2279 - 2287
Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure Kohei HosokawaChiharu SugimoriShinji Nakao Original Article 24 July 2018 Pages: 2289 - 2297
A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs Dorota Link-LenczowskaNiels PallisgaardTomasz Sacha Original Article Open access 28 July 2018 Pages: 2299 - 2308
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts Dong Won BaekYoo Jin LeeJoon Ho Moon Original Article 02 August 2018 Pages: 2309 - 2317
A monocentric retrospective study of 138 therapy-related myeloid neoplasms Helena ClaerhoutEls LiermanNancy Boeckx Original Article 10 September 2018 Pages: 2319 - 2324
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy Esther SchulerNatalie ZadroznyUlrich Germing Original Article 04 August 2018 Pages: 2325 - 2332
Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practice Rory M. ShallisMina L. XuAmer M. Zeidan Original Article 14 August 2018 Pages: 2333 - 2343
Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma Yoshiaki AbeKentaro NaritaKosei Matsue Original Article 23 August 2018 Pages: 2345 - 2352
Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells Lei ZhangJiefeng TongXiaoying Zhao Original Article 11 August 2018 Pages: 2353 - 2362
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms Hee Sang HwangDok Hyun YoonJooryung Huh Original Article 01 August 2018 Pages: 2363 - 2372
Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival Kimberly KeeferRegis BenderAndry Van de Louw Original Article 21 July 2018 Pages: 2373 - 2380
Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4 + CD25 + T cell ratio in early stage NK/T cell lymphoma patients may predict worse outcome Peng-fei LiYi-ze MaoHui-qiang Huang Original Article 16 August 2018 Pages: 2381 - 2389
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma Jonathan FarhiKamel LaribiMarie-Pierre Moles-Moreau Original Article 08 August 2018 Pages: 2391 - 2401
Transient adrenal insufficiency in diffuse large B cell lymphoma patients after chemotherapy with short-course, high-dose corticosteroids Weerapat OwattanapanichSirinart SirinvaravongTaweesak Wannachalee Original Article Open access 14 August 2018 Pages: 2403 - 2410
Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience Francesca De FeliceLavinia GrapulinVincenzo Tombolini Original Article 10 August 2018 Pages: 2411 - 2416
Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series S. BobilloP. Abrisquetaon behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO cooperative group) Original Article 16 August 2018 Pages: 2417 - 2424
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry Rafat AbonourLynne WagnerRobert M. Rifkin Original Article Open access 29 July 2018 Pages: 2425 - 2436
Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms Wolfgang KnaufAli Aldaoudand the TLN-Group (Tumour Registry Lymphatic Neoplasms) Original Article Open access 01 August 2018 Pages: 2437 - 2445
Nucleic acid based risk assessment and staging for clinical practice in multiple myeloma Ritu GuptaGurvinder KaurOm Dutt Sharma Original Article 28 July 2018 Pages: 2447 - 2454
Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study David CellaJan McKendrickCatherine Davis Original Article Open access 04 September 2018 Pages: 2455 - 2463
Clinical presentation and prognosis of light-chain amyloidosis patients with unmeasurable free light-chain levels Yu QiuCong-li ZhangJian Li Original Article 28 July 2018 Pages: 2465 - 2470
Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients Claudio AnnaloroLorena AiraghiAgostino Cortelezzi Original Article 27 July 2018 Pages: 2471 - 2478
Sequential treatment combining cladribine-based re-induction, myeloablative allogeneic HSCT, and prophylactic donor lymphocyte infusion: a promising treatment for refractory acute myeloid leukemia Haowen XiaoLi LiHe Huang Original Article 04 August 2018 Pages: 2479 - 2490
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia Corina SchneidawindVolker HagmaierDominik Schneidawind Original Article 31 July 2018 Pages: 2491 - 2500
Course of colonization by multidrug-resistant organisms after allogeneic hematopoietic cell transplantation D. HeidenreichS. KreilStefan A. Klein Original Article 18 August 2018 Pages: 2501 - 2508
The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients Abbey WillcoxEric WongAndrew Grigg Original Article 26 July 2018 Pages: 2509 - 2518
Management of Dabigatran-associated bleeding in two elderly patients with acute renal failure Christian PfrepperAlexander PeschkaMichael Metze Letter to the Editor 27 May 2018 Pages: 2519 - 2521
Clinical characteristics and treatment outcome of an 86-year-old patient with acute myeloid leukaemia with acute promyelocytic-like morphology and uncommon RARA fusion variant Roberto CastelliValentina RossiFrancesco Lo Coco Letter to the Editor 05 June 2018 Pages: 2523 - 2525
Hairy cell leukemia presenting with progressive pericarditis and pleuritis Atsushi IwashigeMakoto HirosawaJunichi Tsukada Letter to the Editor Open access 30 May 2018 Pages: 2527 - 2528
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma Dai MaruyamaKunihiro TsukasakiKensei Tobinai Correction 27 July 2018 Pages: 2529 - 2530
Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia Andreas TiedeAndrew Worster Correction Open access 28 September 2018 Pages: 2531 - 2531